fbpx
Category

Uncategorized

U.S. Olympic Gymnast, Shannon Miller, to Give ODAC Keynote Address

By | Uncategorized | No Comments

Shannon Miller, 7 time Olympic medalist and leader of the 1996 Magnificent 7, will give the keynote address at the ODAC Dermatology, Aesthetic & Surgical Conference (ODAC). The address, “Gold Medal Mindset with Shannon Miller: Motivation, Teamwork & Commitment to Excellence,” will be given Friday, January 14, at 6:30 p.m. at the Rosen Shingle Creek in Orlando.

Shannon will discuss how the gold medal mindset not only helped her win seven Olympic medals, but also battle cancer, and how these lessons continue to help her through the day-to-day effort of finding that illusive work-life balance. Shannon will share what it takes to succeed: the importance of goal setting, teamwork, positive attitude and resiliency.

“We are honored to have Shannon share her story of overcoming personal challenges, which can be an inspiration to us all,” said Shelley Tanner, CEO and president of SanovaWorks, which produces ODAC. “Shannon serves as the inaugural keynote speaker in recognition of our 20th ODAC. We look forward to developing a long tradition of keynote addresses that inspire and encourage for the year ahead.”

ODAC provides pearls and clinical updates in medical, aesthetic and surgical dermatology through an engaging learning experience, including live demonstrations, panel discussions and audience Q&As. ODAC historically attracts nearly 700 dermatology physicians, residents, nurse practitioners and physician assistants each year. Up to 26.25 AMA PRA Category 1 Credits™ are available. The conference runs from January 14 through January 17.

ODAC is a product of SanovaWorks, publisher of the Journal of Drugs in Dermatology (JDD) and producer of the Skin of Color Update conference.

Registration is available at orlandoderm.org.

My Top Picks of Cosmeceuticals from SkinCeuticals

By | Uncategorized | No Comments
Register Now

My Top Picks of Cosmeceuticals from SkinCeuticals

Tuesday, October 26th, 2021 | 7:00 – 8:00 PM ET

Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. Zoe Draelos, as she shares information on cosmeceutical ingredients. This presentation will include information on the mechanisms of action and benefits for various skin conditions and concerns for ingredients found in SkinCeuticals products.

Speaker
Zoe Diana Draelos, MD
Dermatology Consulting Services, PLLC

PRODUCT GIVEAWAY
US Dermatology healthcare providers who attend the entire webinar will receive one full-sized item from the SkinCeuticals portfolio of skin care products. Products will be distributed by SkinCeuticals based on current inventory. Requests for specific products will not be taken. Shipments will be fulfilled in approximately six to eight weeks following the webinar. This program is only open to US Dermatology healthcare providers. PLEASE BE SURE TO REGISTER WITH THE ADDRESS YOU WOULD LIKE THE PRODUCT SHIPPED TO. ADDRESS CHANGES WILL NOT BE ACCEPTED. For questions about the product giveaway, please contact [email protected].

Register Now

ODAC Pre-Conference Symposium – Free Virtual Event

By | Uncategorized | No Comments

The virtual event is free and open to all healthcare practitioners, however, pre-registration is required.

ODAC 2022 PRE-CONFERENCE SYMPOSIUM
CHALLENGING CASES OF INFLAMMATORY SKIN DISEASES: A CASE-BASED CONVERSATION WITH THE EXPERTS
Tuesday, November 16, 2021 | 5:30PM ET – 8:30 PM ET

Who doesn’t enjoy a little taste, a nibble to entice the educational appetite that will no doubt be satiated by ODAC 2022? No need to answer because we have your fix. The ODAC Virtual Pre-Conference Symposium will be a unique academic appetizer developed using audience feedback to provide the best and most clinically translatable experience for attendees (think mini hot dogs of conferences – if you know, you know). Join us for case based, literature distilling discussions on Acne, Psoriasis, Atopic Dermatitis, and Hidradenitis with experts from across the country. Tune in to digest the repartee between moderator and ODAC co-Chair Dr. Adam Friedman and esteemed faculty, all aimed at filling your clinical dermatology stomachs. Do not pass and make sure to come back for seconds.

AGENDA

5:30-5:35PM ET – Welcome & Introductions – Adam Friedman, MD, FAAD

5:35-5:55PM ET – Challenging Cases of Psoriasis – April W. Armstrong, MD, MPH

5:55-6:15PM ET – Challenging Cases of Acne – Jenna C. Lester, MD

6:15-6:30PM ET – Live Audience Q&A

6:30-7:30PM ET – Non-CME Product Theater Presentation Sponsored by Incyte – Atopic Dermatitis: The Burden of Disease & A Novel Topical Pathway – Adam Friedman, MD, FAAD

7:30-7:35PM ET – Welcome & Introductions – Adam Friedman, MD

7:35-7:55PM ET – Challenging Cases of Atopic Dermatitis – Jonathan Silverberg, MD, PhD, MPH

7:55-8:15PM ET – Challenging Cases of Hidradenitis Suppurativa – Ginette A. Okoye, MD, FAAD

8:15-8:30PM ET – Live Audience Q&A

SYMPOSIUM MODERATOR

Adam Friedman, MD, FAAD

EXPERT FACULTY

April W. Armstrong, MD, MPH
Jenna C. Lester, MD
Ginette A. Okoye, MD, FAAD
Jonathan Silverberg, MD, PhD, MPH

SPONSORED WORKSHOP

Non-CME Product Theater Presentation Sponsored by Incyte
Atopic Dermatitis: The Burden of Disease & A Novel Topical Pathway
Adam Friedman, MD, FAAD
Presentation Sponsored By Incyte Dermatology
*This sponsored workshop is non-CE and will not be recorded.

CLAIMING CE
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. In order to claim CE for this virtual symposium, you must be registered as a ODAC 2022 live attendee. Instructions on how to claim CE will be provided during the ODAC 2022 live event in Orlando, FL on January 14-17, 2022. You can register for ODAC 2022 here. (The sponsored workshop is non-CE.)

VIDEO RECORDING
The recording of the CE portion of this symposium will only be available to re-watch on the ODAC 2022 Onsite App. You must be a ODAC 2022 live attendee to access this platform. (The non-CE sponsored workshop will not be recorded.)

Register Now

JAK/TYK2 Inhibition: New Frontiers in the Treatment of Psoriasis – Virtual CME Event

By | Uncategorized | No Comments

Psoriasis is a common autoimmune disorder with associated comorbidities that are more than skin deep. Patients with psoriasis are at increased risk for cardiovascular and metabolic disease, malignancies, and anxiety/depression. These patients suffer from a diminished quality of life; conversely, treatment of the disease can improve quality of life and reduce morbidity. Unfortunately, data indicate that patients with psoriasis do not receive optimal treatment, and that clinicians are not sufficiently equipped to select appropriate therapy from among the many new treatment options. The proposed educational initiative will provide clinicians with a solid foundation for understanding the pathophysiology of psoriasis along with other autoimmune diseases, how this pathophysiology informs treatment options, and the most recent clinical trial data for current and emerging agents and management recommendations available to guide therapy selection.

SPEAKER
Gary Goldenberg, MD
Assistant Clinical Professor, Dermatology
Mount Sinai School of Medicine
New York, NY

This webinar is hosted by ODAC.
This activity is provided by the University of Cincinnati.
Paradigm Medical Communications, LLC is the educational partner.

DISCLOSURE OF COMMERCIAL SUPPORT
This activity is supported by an educational grant from Bristol-Myers Squibb.

TARGET AUDIENCE
This initiative has been designed to address the educational needs of dermatology clinicians. It may also be of benefit to rheumatology and primary care clinicians, as well as other healthcare providers involved with or interested in the management of patients with psoriasis.

LEARNING OBJECTIVES
Upon proper completion of this activity, participants should be better able to:
– Identify the JAK/TYK2-STAT–mediated pathways involved in the pathophysiology of psoriasis
– Summarize evidence for the efficacy, safety, and mechanisms of action for new and emerging agents in psoriasis, and the implications for treatment
– Apply current research findings and recommendations to the treatment of psoriasis and comorbidities

AGENDA
– Pathophysiology of Psoriasis
– Recent Guidelines
– New Directions in Psoriasis Therapy: The Role of Recently Approved and Emerging Agents
– Tying it Together

ACCREDITATION INFORMATION
Physician Accreditation Statement
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation Statement
The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949 or [email protected].

STEERING COMMITTEE
April W. Armstrong, MD, MPH
Associate Dean, Clinical Research
Professor of Dermatology
Director, Clinical Research Support, Southern California CTSI
Keck School of Medicine
University of Southern California
Los Angeles, CA

Seemal R. Desai, MD, FAAD
Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX

Gary Goldenberg, MD
Assistant Clinical Professor, Dermatology
Mount Sinai School of Medicine
New York, NY

DISCLOSURES
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below. Any potential conflicts of interest have been resolved.

April W. Armstrong, MD MPH
Consulting Fees: Abbvie Inc; Bristol-Meyers Squibb Company; Dermavant Sciences Inc; Eli Lilly and Company; Janssen Pharmaceuticals, Inc; LEO Pharma Inc; Modernizing Medicine; Novartis; Ortho Dermatologics; Pfizer Inc; Regeneron Pharmaceuticals, Inc; Sanofi Genzyme; Sun Pharmaceutical Industries Ltd
Grant/Research Support: Abbvie Inc; Bristol-Meyers Squibb Company; Dermavant Sciences, Inc; Dermira; Eli Lilly and Company; Janssen Pharmaceuticals, Inc; Kyowa Kirin Pharmaceutical Research, Inc; LEO Pharma Inc; Novartis; Regeneron Pharmaceuticals Inc; Sanofi Genzyme; UCB Inc

Seemal R. Desai, MD, FAAD
Consulting Fees: Bristol-Myers Squibb Company; Pfizer Inc
Speakers Bureau: Pfizer Inc

Gary Goldenberg, MD
Consulting Fees: Abbvie Inc; Eli Lilly and Company; Pfizer Inc
Speakers Bureau: Abbvie Inc; Eli Lilly and Company; Pfizer Inc
University of Cincinnati staff members have no financial relationships to disclose.
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Independent peer, resident/fellow, and patient reviewers has no financial relationships to disclose.

RESOLUTION OF CONFLICT OF INTEREST
The University of Cincinnati has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.

DISCLAIMER
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality.

TERMS OF USE AND PRIVACY POLICY
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

CONTACT US
If you have any questions or comments, please email us at [email protected].

© 2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.

Register Now

OMAR N. QUTUB, MD, FAAD, NAMED ODAC DIRECTOR OF EQUITY, DIVERSITY AND INCLUSION

By | Uncategorized | No Comments
Dr. Qutub Headshot

New York (July 13, 2021) – The ODAC Dermatology, Aesthetic & Surgical Conference (ODAC) announced the appointment of Omar N. Qutub, MD, FAAD, to the position of director of equity, diversity and inclusion (EDI). Dr. Qutub is a medical and cosmetic dermatologist in private practice in Portland, Oregon. He will hold the position for the 2022 and 2023 conferences.

“We were impressed with Dr. Qutub’s innovative and impactful ideas for how to make ODAC more inclusive and diverse,” said Shelley Tanner, CEO and president of SanovaWorks, which produces ODAC. “Dr. Qutub’s passion for equity, inclusion and diversity in medicine is action-oriented and inspiring.”

In this role, Dr. Qutub will work closely with the ODAC Advisory Board and ODAC staff to promote the development and implementation of educational offerings aimed at improving cultural competence, diversity and equity within the field of dermatology. In addition, he will assist in creating a conference experience that is conducive to a collaborative learning environment that enhances professional development and advancement for all.

“With a focus on diversity and inclusion, I wholeheartedly believe that we can make strides as a specialty to serve all populations more proactively and thus more effectively,” said Dr. Qutub. “Serving as the director of EDI will invigorate what I view as a valuable aesthetic and medical training ground for young and experienced dermatologists alike.”

A graduate of Howard University College of Medicine, Dr. Qutub completed his dermatology residency at Howard University Hospital and the Veterans Affairs Medical Center in Washington, D.C. “At Howard, our mission was to serve the underserved, and to do so just as we would serve any other population; a lesson never once lost on me to this day,” said Dr. Qutub.

ODAC, which was founded in 2003, historically attracts nearly 800 dermatology physicians and allied health professionals each year. The 2022 event will take place January 14-17 at the Rosen Shingle Creek in Orlando. ODAC is a product of SanovaWorks, publisher of the Journal of Drugs in Dermatology (JDD) and producer of the Skin of Color Update conference.

 

###

SANOVAWORKS TO MATCH CMMP GRANTS FOR MEDICAL STUDENTS

By | Uncategorized | No Comments
CMMP Medical Student National Grant

SanovaWorks has developed a partnership with and in support of Comprehensive Medical Mentoring Program. We are happy to announce that SanovaWorks will match the CMMP Medical Student Grant fund, which was started to help medical students from underrepresented populations with residency preparation expenses. This matching donation will ensure that more students are able to benefit from the grant. We join other partners in support of CMMP’s efforts of mentoring students, promoting diversity in medicine, and giving back to the communities.

READ MORE ABOUT CMMP’S PARTNERSHIPS


Medical Students, Grants are Now Available for Residency Expenses
Comprehensive Medical Mentoring Program (CMMP) is aware that applying to residency can be a daunting process which can also become more stressful given the associated expenses that come with it.

CMMP is providing grants up to $1,000 for rising 4th-year minority medical students as they are preparing for away rotations and residency applications.

IF YOU ARE

    1. a rising 4th-year medical school student, and
    2. applying for residency for the 2022-2023 academic year, and
    3. a member of an underrepresented group in medicine,

SUBMIT your application today!


The application deadline is May 15, 2021


Apply Today:
 https://sanovaworks.com/CMMP-medical-student-grant

JOIN US
SanovaWorks joins institutions that include George Washington University School of Medicine and Health Sciences, Howard University Hospital, Department of Dermatology, Georgetown University School of Medicine, and many others in support of CMMP.

Do you or an organization you know want to add your support to the Medical Student Grant Fund?

Contact Dr. Lauren Payne to add your company’s name to the partnership list: https://www.cmmpmed.org/contact-us/ 

Director of Equity, Diversity and Inclusion (DEDI) Call for Applications

By | Uncategorized | No Comments
ODAC Director of Equity, Diversity, and Inclusion
The ODAC Dermatology, Aesthetic & Surgical Conference is pleased to announce a call for applications for the role of Director of Equity, Diversity and Inclusion (DEDI). This newly defined position will work closely with the ODAC Advisory Board and the @SanovaWorks_ Events Division, to promote the development and implementation of educational offerings aimed at improving cultural competence, diversity, and equity within the field of dermatology. Additionally, this role will assist in creating a conference experience conducive to a collaborative learning environment that enhances professional development and advancement for all.
To qualify for consideration, applicants should possess the following experience and skills:
·    Board-certified dermatologist, 3-5 years out of residency preferred
·    Demonstrated knowledge of inclusive dermatological education that is representative of diverse patient populations
·    Training or teaching facilitation in the field of dermatology
·    Demonstrated leadership role experience with the ability to work independently
·    Commitment to promoting diversity in dermatology as evidenced by current work in healthcare community engagement
·    Strong collaborative skills with the ability to facilitate dialogue and engage in difficult conversations to sustain a culturally responsive environment
·    Excellent written and oral communication skills with knowledge of language sensitive to inclusivity of all backgrounds and communities
·    The Director of Equity, Diversity and Inclusion may not concurrently serve in the same role/capacity at other dermatology conferences

ODAC Announces Leadership Changes

By | Uncategorized | No Comments
Adam Friedman, MD faculty headshot

The ODAC Dermatology, Aesthetic & Surgical Conference (ODAC) recently announced changes to its advisory committee. Dermatologist Adam Friedman, MD, will now serve as ODAC co-chair. Dermatologist and Mohs surgeon James Spencer, MD, will now serve as ODAC co-chair emeritus.

Dr. Friedman, who has served as ODAC medical director since 2017, will now oversee ODAC’s medical dermatology offerings. He will serve alongside dermatologists and Mohs surgeons Joel Cohen, MD, who is co-chair of procedural dermatology, and Susan Weinkle, MD, who is co-chair of aesthetic dermatology. Dr. Friedman also is chair of the GW SMHS Department of Dermatology in Washington, D.C., and is the founding director of the GW Dermatology Residency Program, director of Translational Research in the Department of Dermatology and director of the Supportive Oncodermatology Program at the GW Cancer Center.

“Dr. Friedman has a wealth of knowledge on both medical dermatology and medical education, including how to create compelling educational experiences that translate into improved patient care,” said Shelley Tanner, CEO and president of SanovaWorks, which produces ODAC. “We look forward to his continued contributions for years to come.”

Dr. Spencer, who has served as ODAC chair for 10 years, will now serve as a senior advisor. He will also continue lecturing at ODAC on skin cancer related topics. Dr. Spencer is in private practice in St. Petersburg, Fla., and also serves as clinical professor of dermatology at The Mount Sinai School of Medicine in New York.

“Dr. Spencer has been instrumental in ODAC’s growth since the conference’s inception,” said Ms. Tanner. “We are grateful for his leadership and look forward to his continued impact through his advisory role.”

ODAC, which was founded in 2003, historically attracts nearly 800 dermatology physicians and allied health professionals each year. The 2022 event will take place January 14-17 at the Rosen Shingle Creek in Orlando.

ODAC Medical Director Adam Friedman, MD, Named Chair of GW SMHS Dermatology

By | Uncategorized | No Comments
Adam Friedman, MD faculty headshot

New York (Mar. 17, 2021) – Adam Friedman, MD, medical director of the ODAC Dermatology, Aesthetic & Surgical Conference (ODAC) was recently named chair of the GW SMHS Department of Dermatology in Washington, D.C. Dr. Friedman has served as interim chair since February 2019, and is the founding director of the GW Dermatology Residency Program, director of Translational Research in the Department of Dermatology and director of the Supportive Oncodermatology Program at the GW Cancer Center.

During his time as interim chair, Dr. Friedman further strengthened collaborative ties between ODAC and GW SMHS through multiple and ongoing educational activities, including the GW Translational Science Lecture Series, the award-winning Krazy Kodachromes, and more recently, the 2020 DCAD conference, the GW Appraisal of Acne conference and the Core Crusher Basic Boot Camp Exam Prep Course.

“Dr. Friedman has worked tirelessly to ensure all dermatologists have access to the latest educational developments in the specialty,” said Shelley Tanner, CEO and president of SanovaWorks, which produces ODAC. “He expertly knows how to engage audiences in their education, creating programs that make learning compelling and applicable to daily practice. We are thankful to have his insight at work in our programs.”

Dr. Friedman has served as ODAC medical director since 2017. In this role, Dr. Friedman has been instrumental in cultivating and expanding the medical dermatology section of the educational program, in addition to generating opportunities for residents.

Dr. Friedman also serves on the editorial board of the Journal of Drugs in Dermatology (JDD), hosts the JDD Podcast and is the senior editor of and chairs the Derm In-Review Advisory Council. JDD and Derm In-Review are also products of SanovaWorks.

ODAC, which began in 2003, historically attracts nearly 700 dermatology physicians, residents, nurse practitioners and physician assistants each year. The 2022 event will take place January 14-17 at the Rosen Shingle Creek in Orlando.

###